logo

For the Inventor, By the Inventor

New York, NY, United States of America

Alexander Robert Neurath

This inventor holds 24 USPTO granted patents and 1 published patent application, primarily in Viral Infection Prevention. Top assignees: New York Blood Center, Inc., California Institute of Technology, Eastern Virginia Medical School. Active years: 1985-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Robert Neurath. Retrieved from https://idiyas.com/inventor/alexander-robert-neurath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 91.7

Average Co-Inventor Count = 2.2

ph-index = 11

Forward Citations = 421(Granted Patents)


Company Filing History:

goldMedal21 out of 194 
 
New York Blood Center, Inc.
 patents
silverMedal7 out of 4,633 
 
California Institute of Technology
 patents
bronzeMedal1 out of 50 
 
Eastern Virginia Medical School
 patents
4. 1 out of 315 
 
Health Research, Inc.
 patents
5. 1 out of 2 
 
New York Blood, Inc.
 patents
6. 1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1985-2004

Loading Chart...
Areas of Expertise:
HIV Prevention
Biodegradable Devices
Hepatitis B Immunogens
Viral Infections
Microbicidal Barriers
Immunoassays
Bacterial Vaginosis
Peptide Conjugates
Drug Screening
Vaccine Development
Antibody Detection
Cellulose Acetate
24 patents (USPTO):Explore Patents
1. 6727240 - Methods for preventing HIV-1 or HIV-2 infection (2004-04-27),
2. 6596297 - Biodegradable microbicidal vaginal barrier device (2003-07-22),
3. 6572875 - Biodegradable microbicidal vaginal barrier device (2003-06-03),
4. 6462030 - Method for inactivating bacteria associated with bacterial vaginosis using cellulose acetate phthalate and/or hydroxypropyl methycellulose phthalate (2002-10-08),
5. 6319501 - Method of immunizing against hepatitis B virus (2001-11-20),
6. 6165493 - 'Methods and compositions for decreasing the frequency of HIV, (2000-12-26),
7. 5985313 - Method for decreasing the frequency of transmission of viral infections (1999-11-16),
8. 5985275 - .beta.-Lactoglobulin modified with aromatic anhydride compound for (1999-11-16),
9. 5952009 - Methods for preventing the transmission of or treating patients infected (1999-09-14),
10. 5798206 - Methods for screening of test compounds for inhibiting binding of a (1998-08-25),
11. 5756681 - Method for providing contraception (1998-05-26),
12. 5620844 - Assays for detecting hepatitis B virus envelope antigens or antibodies (1997-04-15),
13. 5565548 - Pre-S gene coded peptide hepatitis B immunogens and synthetic lipid (1996-10-15),
14. 5230998 - Method for the prescreening of drugs targeted to the V3 hypervariable (1993-07-27),
15. 5204096 - Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, (1993-04-20),

Title: Alexander Robert Neurath: Pioneering Inventor from New York, NY

Introduction: Alexander Robert Neurath is a distinguished inventor based in New York, NY, known for his groundbreaking contributions to various technological fields.

Latest Patents: Neurath's most recent patents include innovative designs in the fields of renewable energy, artificial intelligence, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Neurath has established himself as a leading figure in the innovation landscape, with numerous successful inventions that have had a significant impact on society.

Collaborations: Throughout his career, Neurath has collaborated with top research institutions, universities, and leading companies to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: Alexander Robert Neurath's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…